AAAAAA

   
Results: 1-10 |
Results: 10
A synthetic triptycene bisquinone, which blocks nucleoside transport and induces DNA fragmentation, retains its cytotoxic efficacy in daunorubicin-resistant HL-60 cell lines
Authors: Wang, BN Wu, MF Perchellet, EM McIlvain, CJ Sperfslage, BJ Huang, XD Tamura, M Stephany, HA Hua, DH Perchellet, JP
Citation: Bn. Wang et al., A synthetic triptycene bisquinone, which blocks nucleoside transport and induces DNA fragmentation, retains its cytotoxic efficacy in daunorubicin-resistant HL-60 cell lines, INT J ONCOL, 19(6), 2001, pp. 1169-1178
Quinone isomers of the WS-5995 antibiotics: synthetic antitumor agents that inhibit macromolecule synthesis, block nucleoside transport, induce DNA fragmentation, and decrease the growth and viability of L1210 leukemic cellsmore effectively than ellagic acid and genistein in vitro
Authors: Perchellet, EM Sperfslage, BJ Qabaja, G Jones, GA Perchellet, JP
Citation: Em. Perchellet et al., Quinone isomers of the WS-5995 antibiotics: synthetic antitumor agents that inhibit macromolecule synthesis, block nucleoside transport, induce DNA fragmentation, and decrease the growth and viability of L1210 leukemic cellsmore effectively than ellagic acid and genistein in vitro, ANTI-CANC D, 12(5), 2001, pp. 401-417
1,4-Anthraquinone: an anticancer drug that blocks nucleoside transport, inhibits macromolecule synthesis, induces DNA fragmentation, and decreases the growth and viability of L1210 leukemic cells in the same nanomolar range as daunorubicin in vitro
Authors: Perchellet, EM Magill, MJ Huang, XD Dalke, DM Hua, DH Perchellet, JP
Citation: Em. Perchellet et al., 1,4-Anthraquinone: an anticancer drug that blocks nucleoside transport, inhibits macromolecule synthesis, induces DNA fragmentation, and decreases the growth and viability of L1210 leukemic cells in the same nanomolar range as daunorubicin in vitro, ANTI-CANC D, 11(5), 2000, pp. 339-352
Regioselective lactonization of naphthoquinones: synthesis and antitumoralactivity of the WS-5995 antibiotics
Authors: Qabaja, G Perchellet, EM Perchellet, JP Jones, GB
Citation: G. Qabaja et al., Regioselective lactonization of naphthoquinones: synthesis and antitumoralactivity of the WS-5995 antibiotics, TETRAHEDR L, 41(17), 2000, pp. 3007-3010
Triptycenes: a novel synthetic class of bifunctional anticancer drugs thatinhibit nucleoside transport, induce DNA cleavage and decrease the viability of leukemic cells in the nanomolar range in vitro
Authors: Perchellet, EM Magill, MJ Huang, XD Brantis, CE Hua, DH Perchellet, JP
Citation: Em. Perchellet et al., Triptycenes: a novel synthetic class of bifunctional anticancer drugs thatinhibit nucleoside transport, induce DNA cleavage and decrease the viability of leukemic cells in the nanomolar range in vitro, ANTI-CANC D, 10(8), 1999, pp. 749-766
Microtubule-disrupting effects of gallium chloride in vitro
Authors: Perchellet, EM Ladesich, JB Collery, P Perchellet, JP
Citation: Em. Perchellet et al., Microtubule-disrupting effects of gallium chloride in vitro, ANTI-CANC D, 10(5), 1999, pp. 477-488
Tricyclic pyrone analogs: a new synthetic class of bifunctional anticancerdrugs that inhibit nucleoside transport, microtubule assembly, the viability of leukemic cells in vitro and the growth of solid tumors in vivo
Authors: Perchellet, EM Ladesich, JB Magill, MJ Chen, Y Hua, DH Perchellet, JP
Citation: Em. Perchellet et al., Tricyclic pyrone analogs: a new synthetic class of bifunctional anticancerdrugs that inhibit nucleoside transport, microtubule assembly, the viability of leukemic cells in vitro and the growth of solid tumors in vivo, ANTI-CANC D, 10(5), 1999, pp. 489-504
Alterations in focal adhesion kinase activity and associated proteins during malignant conversion of mouse keratinocytes
Authors: Newell, SW Perchellet, JP Perchellet, EM Ulug, ET
Citation: Sw. Newell et al., Alterations in focal adhesion kinase activity and associated proteins during malignant conversion of mouse keratinocytes, MOL CARCINO, 25(1), 1999, pp. 73-83
Racemic 3-(3,4-dimethoxyphenyl)-5a,6,8,9-tetrahydro-1H,7H-pyrano[4,3-b][1]benzo-pryan-1-one, an active antitumor agent
Authors: Robinson, PD Beatty, A Hua, DH Chen, Y Meyers, CY Perchellet, EM Ladesich, JB Perchellet, JP
Citation: Pd. Robinson et al., Racemic 3-(3,4-dimethoxyphenyl)-5a,6,8,9-tetrahydro-1H,7H-pyrano[4,3-b][1]benzo-pryan-1-one, an active antitumor agent, ACT CRYST C, 55, 1999, pp. 1188-1190
6,7,8,9-Tetrahydro-3-methyl-1H-pyrano[4,3-b]quinolin-1-one
Authors: Hua, DH Chen, Y Sin, HS Robinson, PD Meyers, CY Perchellet, EM Perchellet, JP Chiang, PK Biellmann, JF
Citation: Dh. Hua et al., 6,7,8,9-Tetrahydro-3-methyl-1H-pyrano[4,3-b]quinolin-1-one, ACT CRYST C, 55, 1999, pp. 1698-1701
Risultati: 1-10 |